These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37887200)

  • 1. Incidence of Rifampicin Resistance in Periprosthetic Joint Infection: A Single-Centre Cohort Study on 238 Patients.
    Lazarinis S; Hailer NP; Järhult JD; Brüggemann A
    Antibiotics (Basel); 2023 Sep; 12(10):. PubMed ID: 37887200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Staphylococcal Periprosthetic Joint Infection (PJI) Treated with Debridement, Antibiotics, and Implant Retention (DAIR): Inferior Outcomes in Patients with Staphylococci Resistant to Rifampicin.
    Eriksson HK; Lazarinis S; Järhult JD; Hailer NP
    Antibiotics (Basel); 2023 Nov; 12(11):. PubMed ID: 37998791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased rate of enteric bacteria as cause of periprosthetic joint infections in patients with liver cirrhosis.
    Koepf US; Scheidt S; Hischebeth GTR; Strassburg CP; Wirtz DC; Randau TM; Lutz P
    BMC Infect Dis; 2022 Apr; 22(1):389. PubMed ID: 35439971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiological pattern of prosthetic hip and knee infections: a high-volume, single-centre experience in China.
    Yu Y; Kong Y; Ye J; Wang A; Si W
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33448922
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgery Before Subspecialty Referral for Periprosthetic Knee Infection Reduces the Likelihood of Infection Control.
    Song SY; Goodman SB; Suh G; Finlay AK; Huddleston JI; Maloney WJ; Amanatullah DF
    Clin Orthop Relat Res; 2018 Oct; 476(10):1995-2002. PubMed ID: 30179927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study.
    Kramer TS; Soriano A; Tedeschi S; Chen AF; Tattevin P; Senneville E; Gomez-Junyent J; Birlutiu V; Petersdorf S; de Brito VD; Gonzalez IS; Belden KA; Wouthuyzen-Bakker M
    Open Forum Infect Dis; 2023 Oct; 10(10):ofad491. PubMed ID: 37901121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics of Staphylococcus aureus and Staphylococcus epidermidis from Periprosthetic Joint Infections and Correlation to Clinical Outcome.
    Trobos M; Firdaus R; Svensson Malchau K; Tillander J; Arnellos D; Rolfson O; Thomsen P; Lasa I
    Microbiol Spectr; 2022 Aug; 10(4):e0218121. PubMed ID: 35762769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with a History of Treated Septic Arthritis are at High Risk of Periprosthetic Joint Infection after Total Joint Arthroplasty.
    Sultan AA; Mahmood B; Samuel LT; George J; Faour M; Pelt CE; Anderson MB; Klika AK; Higuera CA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1605-1612. PubMed ID: 30913112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilm properties in relation to treatment outcome in patients with first-time periprosthetic hip or knee joint infection.
    Svensson Malchau K; Tillander J; Zaborowska M; Hoffman M; Lasa I; Thomsen P; Malchau H; Rolfson O; Trobos M
    J Orthop Translat; 2021 Sep; 30():31-40. PubMed ID: 34485075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampin-resistant periprosthetic joint infections are associated with worse functional outcome in both acute and chronic infection types.
    Baumgärtner T; Bdeir M; Dally FJ; Gravius S; Hai AAE; Assaf E; Hetjens S; Miethke T; Darwich A
    Diagn Microbiol Infect Dis; 2024 Oct; 110(2):116447. PubMed ID: 39111108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure.
    Manasherob R; Mooney JA; Lowenberg DW; Bollyky PL; Amanatullah DF
    Clin Orthop Relat Res; 2021 Jul; 479(7):1471-1481. PubMed ID: 33835090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic bacteria characteristics and drug resistance in acute, delayed, and chronic periprosthetic joint infection: A retrospective analysis of 202 patients.
    Chang Y; Li Y; Fan T; Jiang K; Lv J; Huang J
    Int Wound J; 2023 Oct; 20(8):3315-3323. PubMed ID: 37186450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truth in DAIR: Duration of Therapy and the Use of Quinolone/Rifampin-Based Regimens After Debridement and Implant Retention for Periprosthetic Joint Infections.
    Tai DBG; Berbari EF; Suh GA; Lahr BD; Abdel MP; Tande AJ
    Open Forum Infect Dis; 2022 Sep; 9(9):ofac363. PubMed ID: 36072695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of hip and knee periprosthetic joint infections caused by pathogens resistant to biofilm-active antibiotics: results from a prospective cohort study.
    Akgün D; Perka C; Trampuz A; Renz N
    Arch Orthop Trauma Surg; 2018 May; 138(5):635-642. PubMed ID: 29352435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprosthetic joint infection in patients with multiple arthroplasties.
    Sangaletti R; Zanna L; Akkaya M; Sandiford N; Ekhtiari S; Gehrke T; Citak M
    Bone Joint J; 2023 Mar; 105-B(3):294-300. PubMed ID: 36854322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the effect of rifampicin resistance and risk factors on recovery rates after DAIR procedure in patients with prosthetic joint infection.
    Krizsán G; Sallai I; Veres DS; Prinz G; Kovács M; Skaliczki G
    J Orthop Surg Res; 2023 Aug; 18(1):611. PubMed ID: 37605214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study-The ARTHR-IS Study Group.
    Espíndola R; Vella V; Benito N; Mur I; Tedeschi S; Zamparini E; Hendriks JGE; Sorlí L; Murillo O; Soldevila L; Scarborough M; Scarborough C; Kluytmans J; Ferrari MC; Pletz MW; Mcnamara I; Escudero-Sanchez R; Arvieux C; Batailler C; Dauchy FA; Liu WY; Lora-Tamayo J; Praena J; Ustianowski A; Cinconze E; Pellegrini M; Bagnoli F; Rodríguez-Baño J; Del Toro MD;
    Infect Dis Ther; 2022 Dec; 11(6):2177-2203. PubMed ID: 36242742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower Success Rate of Débridement and Implant Retention in Late Acute versus Early Acute Periprosthetic Joint Infection Caused by Staphylococcus spp. Results from a Matched Cohort Study.
    Wouthuyzen-Bakker M; Sebillotte M; Huotari K; Escudero Sánchez R; Benavent E; Parvizi J; Fernandez-Sampedro M; Barbero JM; Garcia-Cañete J; Trebse R; Del Toro M; Diaz-Brito V; Sanchez M; Scarborough M; Soriano A;
    Clin Orthop Relat Res; 2020 Jun; 478(6):1348-1355. PubMed ID: 32106134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of pathogen distribution and drug resistance of acute,delayed and chronic periprosthetic joint infection].
    Zhou LC; Li GQ; Xu BY; Mamtimin A; Cao L; Zhang XG
    Zhonghua Wai Ke Za Zhi; 2021 Jun; 59(6):484-490. PubMed ID: 34102732
    [No Abstract]   [Full Text] [Related]  

  • 20. One-stage exchange should be avoided in periprosthetic joint infection cases with massive femoral bone loss or with history of any failed revision to treat periprosthetic joint infection.
    Slullitel PA; Oñativia JI; Zanotti G; Comba F; Piccaluga F; Buttaro MA
    Bone Joint J; 2021 Jul; 103-B(7):1247-1253. PubMed ID: 34192931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.